- Home
- /
- Treatment
- /
- Page 24
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Hematopoietic stem cells modified with a lentiviral vector containing the CD18 (Integrin Beta 2) gene | Leukocyte adhesion deficiency Type I | Consorcio Centro de Investigaci�n Biom�dica en Red, M.P.;Montforte de Lemos, 3-5 Pabellon 11;Madrid | November 9, 2016 | |
NiCord (cord blood-derived exvivo expanded CD34+ cells and the non-expanded cell fraction of the same cord blood unit) | Chronic myeloid leukemia | Gamida Cell Ltd.;P. O. Box 34670;Jerusalem | November 9, 2016 | |
Rituximab | Rasmussen's encephalitis | Keck Graduate Institute of Applied Life Sciences;535 Watson Drive;Claremont, California, 91711 | November 9, 2016 | |
Recombinant growth hormone fused to hyFc | Growth hormone deficiency | Genexine, Inc.;700 Daewangpangyo-ro, Korea Bio Pk Bldg B, Bundang-gu;Gyeonggi-do | November 9, 2016 | |
Autologous stromal vascular cell fraction from adipose tissue (central facitily processed) | Systemic scleroderma | Cytori Therapuetics, Inc.;3020 Callan Road;San Diego, California, 92121 | November 9, 2016 | |
6-(4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one hydrochloride | Pulmonary Arterial Hypertension | Reviva Pharmaceuticals, Inc.;3900 Freedom Circle, Suite 101;Santa Clara, California, 95054 | November 9, 2016 | |
Riboflavin-vitamin E-TPGS topical solution | Keratoconus | Institute of Refractive & Ophthalmic Surgery;Via Andrea D'Isernia 31,;Napoli | November 8, 2016 | |
Aganirsen | Prevention of corneal graft rejection | Gene Signal International SA;Route Cantonale;Lausanne | November 7, 2016 | |
2-[4-[[(2R)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]thio]-2-methylphenoxy]acetic acid (1:1) lysine dihydrate | Primary biliary cirrhosis | CymaBay Therapeutics;7999 Gateway Boulevard, Suite 130;Newark, California, 94560 | November 7, 2016 | |
H-(4-amino-3-iodo)-D-Phe-c[Cys-(3-iodo)-Tyr-D-Trp-Lys-Val-Cys]-Thr-NH2 | Acromegaly | Amryt Research Ltd.;18 Fitzwilliam Place;Dublin | November 3, 2016 | |
6′-(R)-Methyl-5-O-(5-amino-5,6-dideoxy-a-L-talofuranosyl)- paromamine sulfate | Rett syndrome | Eloxx Pharmaceuticals, Ltd.;Weizmann Science Park, 7 Golda Meir Street;Ness Ziona | November 3, 2016 | |
2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate | Coccidioidomycosis | Amplyx Pharmaceuticals, Inc.;12730 High Bluff Drive, Suite 160;San Diego, California, 92130 | November 3, 2016 | |
Veliparib | Non-small cell lung cancer | AbbVie Inc.;1 North Waukegan Road;North Chicago, Illinois, 60064 | November 3, 2016 | |
Ruxolitinib | Graft Versus Host Disease | Incyte Corporation;1801 Augustine Cut-Off;Wilmington, Delaware, 19803 | November 3, 2016 | |
Melatonin | Smith-magenis syndrome in combination with a beta-blocker | Therapicon SrL;21 Via Malachia Marchesi de Taddei;Milano | November 3, 2016 | |
2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate | Invasive rare mold infections caused by scedosporium spp., fusarium spp., and mucorales fungi (including mucor spp., and rhizopus spp.) | Amplyx Pharmaceuticals, Inc.;12730 High Bluff Drive, Suite 160;San Diego, California, 92130 | November 2, 2016 | |
2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate | Invasive aspergillosis | Amplyx Pharmaceuticals, Inc.;12730 High Bluff Drive, Suite 160;San Diego, California, 92130 | October 26, 2016 | |
Napabucasin | Pancreatic cancer | Boston Biomedical, Inc.;640 Memorial Drive;Cambridge, Massachusetts, 02139 | October 25, 2016 | |
Sofosbuvir | Pediatric chronic hepatitis C virus infection | Gilead Sciences, Inc.;333 Lakeside Drive;Foster City, California, 94404 | October 25, 2016 | |
Rapamycin | Pulmonary arterial hypertention | Lam Therapeutics;530 Old Whitfield Street;Guilford, Connecticut, 06437 | October 20, 2016 | |
Partial agonist at the opioid receptor-like 1 receptor with amino acid sequence Ac-Arg-Tyr-Tyr-Arg-Trp-Lys-Lys-Lys-Lys-Lys-Lys-Lys-NH2 | Pulmonary Arterial Hypertension | Serodus ASA;Gaustadall�en 21;Oslo | October 19, 2016 | |
2-amino-3-[3-[[4-(2-pyridyloxymethyl)phenyl]methyl]isoxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate | Invasive candidiasis | Amplyx Pharmaceuticals, Inc.;12730 High Bluff Drive, Suite 160;San Diego, California, 92130 | October 19, 2016 | |
Fixed dose combination formulation of macitentan and tadalafil | Pulmonary Arterial Hypertension | Actelion Clinical Research, Inc.;1820 Chapel Avenue West, Suite 300;Cherry Hill, New Jersey, 08002 | October 19, 2016 | |
6-(R)-Methyl-5-O-(5-amino-5,6-dideoxy-a-L-talofuranosyl)- paromamine sulfate | Hurler syndrome | Eloxx Pharmaceuticals, Ltd.;Weizmann Science Park, 7 Golda Meir Street;Ness Ziona | October 18, 2016 | |
Crenolanib besylate | Acute myeloid leukemia | Arog Pharmaceuticals Europe Ltd | October 14, 2016 |